REDAPT Anteverted Cemented Liner— 510(k) K160923

Substantially Equivalent

Smith & Nephew, Inc.

FDA 510(k) clearance K160923 for REDAPT Anteverted Cemented Liner, Substantially Equivalent on 2016-11-17. Applicant: Smith & Nephew, Inc..

Clearance details

Applicant: Smith & Nephew, Inc.
Product code: Code JDI
Advisory panel: Orthopedic
Date received: 2016-04-04
Decision date: 2016-11-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cordova, TN, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code JDI

product code JDI

Death: 65
Injury: 12,943
Malfunction: 1,681
Total: 14,689

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.